Mylan Plans Half-Priced Generic Version of EpiPen

The video discusses Mylan's strategy to release a generic version of the EpiPen in response to criticism over high prices. It explores the dynamics of the pharmaceutical market, including competition and pricing strategies. The video also addresses congressional scrutiny and the legislative efforts that allowed Mylan to increase EpiPen prices steadily over time.

What is Mylan's primary strategy to address criticism and potential competition?

• Lowering the price of the branded EpiPen

• Introducing a generic version of the EpiPen

• Partnering with other pharmaceutical companies

• Discontinuing the EpiPen

Why do pharmaceutical companies sometimes create generic versions of their own branded products?

• To ensure their product's success amidst generic competition

• To eliminate competition

• To increase the price of the branded product

• To reduce production costs

How do companies typically respond to impending generic competition?

• By merging with competitors

• By discontinuing the product

• By lowering the price of their branded product

• By increasing the price to maintain margins

What was Congress's reaction to Mylan's pricing strategy?

• They praised it as innovative

• They ignored it

• They called it a PR stunt

• They supported it

How did Mylan manage to increase the price of the EpiPen over the years?

• By making sudden large price hikes

• By steadily increasing the price

• By reducing the number of pens in a pack

• By introducing new features